Our study found that valsartan treatment reduces the production and secretion of inflammatory cytokines (IL-6, TNF-a, IL-1β) and MUC5AC in both LPS-treated human BEAS-2B cells and mouse ALI models. The gene discussed is TNF; the disease is acute respiratory distress syndrome.